Biogen Financial Overview
Biogen's market cap is currently $25.16B. The company's EPS TTM is $4.81; its P/E ratio is 15.70; Biogen is scheduled to report earnings on October 30, 2025, and the estimated EPS forecast is $1.74. See an overview of income statement, balance sheet, and cash flow financials.
